Comparison of Breast Fine-Needle Aspiration Cytology and Tissue Sampling for High-Throughput Proteomic Analysis and Cancer Biomarker Detection
Pathobiology · 2024
DOI: 10.1159/000539478 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pathobiology, 2024. Verfasst von Hye Eun Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Seoul National University Boramae Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Proteomics, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Introduction
Fine-needle aspiration cytology (FNAC) specimens are widely utilized for the diagnosis and molecular testing of various cancers. We performed a comparative proteomic analysis of three different sample types, including breast FNAC, core needle biopsy (CNB), and surgical resection tissues. Our goal was to evaluate the suitability of FNAC for in-depth proteomic analysis and for identifying potential therapeutic biomarkers in breast cancer.
Methods
High-throughput proteomic analysis was conducted on matched FNAC, CNB, and surgical resection tissue samples obtained from breast cancer patients. The protein identification, including currently established or promising therapeutic targets, was compared among the three different sample types. Gene Ontology (GO) enrichment analysis was also performed on all matched samples.
Results
Compared to tissue samples, FNAC testing revealed a comparable number of proteins (7,179 in FNAC; 7,196 in CNB; and 7,190 in resection samples). Around 85% of proteins were mutually identified in all sample types. FNAC, along with CNB, showed a positive correlation between the number of enrolled tumor cells and identified proteins. In the GO analysis, the FNAC samples demonstrated a higher number of genes for each pathway and GO terms than tissue samples. CCND1, CDK6, HER2, and IGF1R were found in higher quantities in the FNAC compared to tissue samples, while TUBB2A was only detected in the former.
Conclusion
FNAC is suitable for high-throughput proteomic analysis, in addition to an emerging source that could be used to identify and quantify novel cancer biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Seoul National University Boramae Hospital, Seoul, Republic of Korea.
- Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Transdisciplinary Department of Medicine and Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.
- Proteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Pathology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
- School of Medicine, European University Cyprus, Nicosia, Cyprus.
Zitieren
APA
Park, H. E., Han, D., Lee, J. S., Nikas, I. P., Kim, H., Yang, S., Lee, H., & Ryu, H. S. (2024). Comparison of Breast Fine-Needle Aspiration Cytology and Tissue Sampling for High-Throughput Proteomic Analysis and Cancer Biomarker Detection. Pathobiology. https://doi.org/10.1159/000539478
Vancouver
Park HE, Han D, Lee JS, Nikas IP, Kim H, Yang S, et al. Comparison of Breast Fine-Needle Aspiration Cytology and Tissue Sampling for High-Throughput Proteomic Analysis and Cancer Biomarker Detection. Pathobiology. 2024. doi:10.1159/000539478
BibTeX
@article{Park2024,
author = {Park, Hye Eun and Han, Dohyun and Lee, Jae Seok and Nikas, Ilias P and Kim, Hyeyoon and Yang, Sohyeon and Lee, Hyebin and Ryu, Han Suk},
title = {Comparison of Breast Fine-Needle Aspiration Cytology and Tissue Sampling for High-Throughput Proteomic Analysis and Cancer Biomarker Detection},
journal = {Pathobiology},
year = {2024},
doi = {10.1159/000539478}
}
EUVIMED